Diabetes and the maternal resistance vasculature

Clinical Science

Volumn 101, Issue 6, 2001, Pages 719-729

  Ang, C ^a   Lumsden, M A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Diabetes; Endothelial function; Insulin; Pregnancy; Small arteries

Indexed keywords

BLOOD VESSEL REACTIVITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MATERNAL DIABETES MELLITUS; MORBIDITY; MORTALITY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; TISSUE PERFUSION; VASCULAR ENDOTHELIUM;

DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PREGNANCY; PREGNANCY IN DIABETICS; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 0035212646     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010153     Document Type: Review

References (127)

1. The biochemistry of the complications of diabetes
2. Diabetic retinopathy: A synthesis of perspectives
3. Pathogenesis of diabetic microangiopathy: The haemodynamic view
4. Preeclampsia in diabetic pregnancies
5. Medical disorders in pregnancy: Diabetes, thyroid disease, epilepsy
6. Preeclampsia: More than pregnancy-induced hypertension
7. Abnormal endothelial cell function of resistance arteries from women with pre-eclampsia
8. + channels in cerebral artery smooth muscle cells
9. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells
10. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
11. Endothelium-derived relaxing factor and converting enzyme inhibition
12. Nitric oxide: Physiology, pathophysiology, and pharmacology
13. Role of endothelial-derived nitric oxide in the regulation of blood pressure
14. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
15. Endothelium-dependent relaxation in human resistance arteries in pregnancy
16. Role of nitric oxide in the regulation of vascular tone in pressurised and perfused resistance myometrial arteries from term pregnant women
17. Endothelium-derived hyperpolarizing factor: Identification and mechanisms of action in human subcutaneous resistance arteries
18. Effects of acetylcholine on the smooth muscle cell of isolated main coronary artery of the guinea-pig
19. The effects of acetylcholine on the membrane and contractile properties of smooth muscle cells of the rabbit superior mesenteric artery
20. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
21. Electrical responses of smooth muscle ceils during cholinergic vasodilation in the rabbit saphenous artery
22. Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery
23. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels
24. Endothelium-dependent hyperpolarization of canine-coronary smooth muscle
25. + is an endothelium-derived hyperpolarizing factor in rat arteries
26. Evidence against potassium ion as an endothelium-derived hyperpolarizing factor in rat mesenteric small arteries
27. Potassium does not mimic EDHF in rat mesenteric arteries
28. + but may be due to spread of current from the endothelium in guinea pig arterioles
29. + currents underlying the action of endothelium-derived hyperpolarizing factor in guinea pig, rat and human blood vessels
30. Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses
31. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation
32. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery
33. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: An important role for endothelium-derived hyperpolarizing factor (EDHF)
34. Involvement of voltage-dependent potassium channels in EDHF-mediated relaxation of the rat hepatic artery
35. Characterisation of potassium channels involved in EDHF-mediated relaxation in cerebral arteries
36. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals
37. Effect of potassium channel blockers on L-NAME insensitive relaxation in rat small mesenteric artery
38. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium
39. Heterogeneous behaviour of the canine arterial and venous wall: Importance of the endothelium
40. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s)
41. Physiological role of the endothelin system in human cardiovascular and renal haemodynamics
42. Organisation of the gene encoding the human endothelin-converting enzyme (ECE-1)
43. Molecular characterisation of human and bovine endothelin converting enzyme (ECE-1)
44. Identification and characterisation of two isoforms of endothelin-converting enzyme-1
45. Signal transduction mechanisms mediating the vascular actions of ET
46. Molecular and cellular biology of endothelin and its receptors -Part II
47. Growth factor activity of endothelin on vascular smooth muscle
48. B receptor mediates both vasodilatation and vasoconstriction in vivo
49. Endothelin receptor subtypes in resistance arteries from humans and rats
50. Comparative studies with endothelin receptor antagonists BQ-123 and PD142893 indicate at least three endothelin receptors
51. Pharmacological evidence for the presence of three distinct functional endothelin subtypes in the rabbit saphenous vein
52. Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries
53. Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies
54. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
55. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice
56. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus
57. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent
58. Abnormalities of endothelial function in patients with predialysis renal failure
59. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus
60. 2
61. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type 1 diabetes
62. Endothelium-dependent vascular relaxation in patients with type 1 diabetes
63. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats
64. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes
65. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: Importance of disease duration
66. Endothelial control of vascular tone in diabetes mellitus
67. Endothelial dysfunction in diabetes
68. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study
69. Prevalence of diabetic complications in relation to risk factors
70. Superoxide anion is an endothelium-derived contracting factor
71. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease
72. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
73. Oxidised low-density lipoprotein antagonises the activation of purified soluble guanylate cylcase by endothelium-derived relaxing factor but does not interfere with its biosynthesis
74. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidised low-density lipoprotein
75. Diabetes Control and Complications Trial (DCCT) update
76. Diabetes mellitus and its degenerative complications: A study of 4400 patients observed between 1947 and 1973
77. Hypercholesterolaemia in diabetes and glucose intolerance in the US population
78. Hyperlipidaemia of diabetes
79. Native and oxidised low density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
80. Pathophysiology of hyperlipidaemia in diabetes mellitus
81. Plasma llpids and microangiopathy in insulin-dependent diabetes mellitus
82. Contraction and endothelium-dependent relaxation in mesenteric microvessels from pregnant rats
83. Myogenic and flow-mediated responses in isolated mesenteric small arteries from pregnant and non-pregnant rats
84. Cardiovascular responses to circulating catecholamines in normal pregnancy and pregnancy-induced hypertension
85. A study of angiotensin II pressor response throughout primigravid pregnancy
86. Nitric oxide-mediated vasodilation in human pregnancy
87. Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy
88. Effect of pregnancy and sex steroids on alpha-1 adrenoceptor mechanisms in the guinea-pig uterine vascular bed
89. Neurovascular function in the rat during pregnancy
90. Nitric oxide activity in the peripheral vasculature during normotensive and preedamptic pregnancy
91. The action of nitric oxide in the perfused human fetal-placental circulation
92. Influence of the oestrous cycle and pregnancy on the reactivity of the rat mesenteric vascular bed
93. Bradykininmediated relaxation of isolated maternal resistanc-earteries in normal pregnancy and pre-eclampsia
94. Endothelin-1 binding sites and immunoreactivity in the human placental trophoblast. Evidence for an autocrine and paracrine role for endothelin-1
95. Maternal and fetal levels of a novel polypeptide endothelin: Evidence for release during pregnancy and delivery
96. Endothelin-induced vasoconstriction is increased in pregnancy
97. Diabetes care and research in Europe: The St Vincent Declaration
98. Preeclampsia: An endothelial cell disorder
99. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells
100. Qualitative assessment of the uteroplacental blood flow: Early screening tests for high risk pregnancies
101. Reduced prostacyclin production by umbilical arteries from pregnancies complicated by severe pregnancy-induced hypertension
102. Association of gestationai diabetes with abnormal maternal vascular endothelial function
103. Prostacyclin in normal and hypertensive pregnancy
104. Endothelium-dependent contractions to acetylchollne in the aorta of the spontaneously hypertensive rat
105. Plasma endothelin in normal and diabetic pregnancy
106. Endothelin, elastase and endothelial dysfunction in pre-eclampsia
107. Plasma endothelin levels in patients with acute renal failure
108. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
109. Sensitivity to endothelin is reduced in pregnant diabetic women
110. Maternal diabetes mellitus - Effects on the fetus and placenta
111. Diabetes during pregnancy
112. Nitric oxide synthase activity in umbilical and placental vascular tissue of gestational diabetic pregnancies
113. Alterations in human fetal-placental vasoreactivity following treatment with peroxynitrite in vitro
114. Increased nitrotyrosine in the diabetic placenta: Evidence for oxidative stress
115. Influence of age and menopause on serum lipids and lipoproteins in healthy women
116. The hyperlipidaemia of pregnancy in normal and complicated pregnancies
117. Lipids and the pathogenesis of pre-eclampsia
118. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia
119. Correlation of hormones with lipid and lipoprotein levels during normal human pregnancy and postpartum
120. Serum lipids in pregnancy and in the puerperium
121. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats
122. Endothelial dysfunction by acute hyperhomocysteinaemia: Restoration by folic acid
123. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolaemia. A randomised placebo-controlled trial
124. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
125. The effect of vitamin E on antioxidant tissue activity in pregnant rats with streptozotocin-induced diabetes
126. Nifedipine improves endothelial function in hypercholesterolaemia, independently of an effect on blood pressure or plasma lipids